RSC Advances
Paper
Chem. Commun., 2010, 46, 3004; (d) D. Q. Xu, Y. F. Wang, 10 (a) K. Tanaka, X. Cheng, T. Kimura and F. Yoneda, Chem.
W. Zhang, S. P. Luo, A. G. Zhong, A. B. Xia and Z. Y. Xu,
Chem.–Eur. J., 2010, 16, 4177; (e) L. Dai, S. Wang and
F. Chen, Adv. Synth. Catal., 2010, 352, 2137; (f) H. Y. Bae,
S. Some, J. H. Lee, J. Kim, M. J. Song, S. Lee, Y. J. Zhang
and C. E. Song, Adv. Synth. Catal., 2011, 353, 3196; (g)
Pharm. Bull., 1986, 34, 3945; (b) K. Tanaka, X. Cheng and
F. Yoneda, Tetrahedron, 1988, 44, 3241; (c) A. Ikeda,
Y. Kawabe, T. Sakai and K. Kaeasaki, Chem. Lett., 1989,
1803; (d) J. D. Figueroa-Villar, C. E. Rangel and L. N. Dos
Santos, Synth. Commun., 1992, 22, 1159.
W. Yang and D. Du, Adv. Synth. Catal., 2011, 353, 1241; (h) 11 (a) M. Bauer and S. Spange, Angew. Chem., Int. Ed., 2011, 50,
´
J. Aleman, A. Parra, H. Jiang and K. A. Jøgensen, Chem.–
9727; (b) A. Niemz and V. M. Rotello, Acc. Chem. Res., 1999,
32, 44; (c) S. S. Agasti, S. T. Caldwell, G. Cooke,
B. J. Jordan, A. Kennedy, N. Kryvokhyzha, G. Rabani,
S. Rana, A. Sanyalc and V. M. Rotello, Chem. Commun.,
2008, 4123.
Eur. J., 2011, 17, 6890; (i) R. I. Storer, C. Aciro and
L. H. Jones, Chem. Soc. Rev., 2011, 40, 2330; (j) D. Mailhol,
M. D. M. S. Duque, W. Raimondi, D. Bonne,
T. Constantieux, Y. Coquerel and J. Rodriguez, Adv. Synth.
Catal., 2012, 354, 3523; (k) P. Kasaplar, P. Riente, 12 I. Bolz, D. Schaarschmidt, T. Ruffer, H. Lang and S. Spange,
`
C. Hartmann and M. A. Pericas, Adv. Synth. Catal., 2012,
Angew. Chem., Int. Ed., 2009, 48, 7440.
354, 2905; (l) H. Yu, Q. Wang, Y. Wang, H. Song, Z. Zhou 13 D. Benito-Garagorri, E. Becker, J. Wiedermann, W. Lackner,
and C. Tang, Chem.–Asian J., 2013, 8, 2859; (m) H. Wang,
Y. Wang, H. Song, Z. Zhou and C. Tang, Eur. J. Org. Chem.,
M. Pollak, K. Mereiter, J. Kisala and K. Kirchner,
Organometallics, 2006, 25, 1900.
2013, 48441; (n) T. Lu and S. E. Wheeler, Chem.–Eur. J., 14 Z. Xu, P. Daka, I. Budik, H. Wang, F. Q. Bai and H. X. Zhang,
2013, 19, 15141; (o) Y. Liu, Y. Wang, H. Song, Z. Zhou and
C. Tang, Adv. Synth. Catal., 2013, 355, 2544.
5 (a) K. P. Nair, V. Breedveld and M. Weck, Macromolecules,
Eur. J. Org. Chem., 2009, 4581.
15 M. Habel, C. Niederalt, S. Grimme, M. Nieger and F. Vogtle,
Eur. J. Org. Chem., 1998, 1471.
´
´
2008, 41, 3429; (b) F. Herbst, K. Schroeter, I. Gunkel, 16 J. Barluenga, J. M. Alvarez-Gutierrez, A. Ballesteros and
´
S. Groeger, T. Thurn-Albrecht, J. Balbach and W. H. Binder, J. M. Gonzalez, Angew. Chem., Int. Ed., 2007, 46, 1281.
Macromolecules, 2010, 43, 10006; (c) K. P. Nair, V. Breedveld 17 (a) Z. Tian, A. Fattahi, L. Lis and S. R. Kass, J. Am. Chem. Soc.,
and M. Weck, So Matter, 2011, 7, 533; (d) S. Seiffert and
J. Sprakel, Chem. Soc. Rev., 2012, 41, 909.
2009, 131, 16984; (b) A. Shokri, X. B. Wang and S. R. Kass, J.
Am. Chem. Soc., 2013, 135, 9525.
6 (a) Y. Ducharme and J. D. Wuest, J. Org. Chem., 1988, 53, 18 K. M. Lippert, K. Hof, D. Gerbig, D. Ley, H. Hausmann,
5787; (b) W. L. Jørgensen and J. Pranata, J. Am. Chem. Soc.,
1990, 112, 2008; (c) J. Pranta, S. G. Wierschke and
S. Guenther and P. R. Schreiner, Eur. J. Org. Chem., 2012,
5919.
W. L. Jørgensen, J. Am. Chem. Soc., 1991, 113, 2810; (d) 19 All reactions were conducted with 0.025 mmol of
J. Sartorius and H. J. Schneider, Chem.–Eur. J., 1996, 2,
1446; (e) F. H. Beijer, H. Kooijman, A. L. Spek,
R. P. Sijbesma and E. W. Meijer, Angew. Chem., Int. Ed.,
1998, 37, 75.
7 (a) W. K. Chan, W. Y. Yu, C. M. Che and M. K. Wong, J. Org.
Chem., 2003, 68, 6576; (b) Y. S. Fung, S. C. Yan and
M. K. Wong, Org. Biomol. Chem., 2012, 10, 3122.
benzylidene barbiturate 5a, 0.25 mmol of 2-methylfuran,
0.03 mmol of internal standard dichloromethane and 20
mol% of HB-DAD organocatalysts. The solutions were
mixed thoroughly. The rst NMR spectrum was taken 5
min aer the addition of 2-methylfuran. Additional NMR
spectra were recorded every 5 min for a total of 120 min.
20 (a) A. Wittkopp and P. R. Schreiner, Chem.–Eur. J., 2003, 9,
407; (b) P. N. H. Huynh, R. R. Walvoord and
M. C. Kozlowski, J. Am. Chem. Soc., 2012, 134, 15621.
8 G. L. Li, K. K. Y. Kung, L. Zou, H. C. Chong, Y. C. Leung,
K. H. Wong and M. K. Wong, Chem. Commun., 2012, 48, 3527.
9 (a) D. G. Barceloux, Barbiturates: Amobarbital, Butalbital, 21 The calculation of relative rate constant of 1a, kobs(1a) ¼
Pentobarbital, Secobarbital, in Medical Toxicology of Drug
Abuse: Synthesized Chemicals and Psychoactive Plants, John
Wiley and Sons, 2012, pp. 467–485; (b) R. Michelucci,
E. Pansini, C. Tassinari, Phenobarbital, Primidone and
0.000148 sꢁ1, kobs(background) ¼ kuncata ¼ 0.0000377 sꢁ1, kcat
¼ kobs(1a) ꢁ kuncata ¼ 0.000148 ꢁ 0.0000377 ¼ 0.000111
sꢁ1, krel ¼ kcat/kuncata ¼ 0.000111/0.000038 ¼ 2.9 at 20
mol% of 1a.
Other Barbiturates, in The Treatment of Epilepsy, Wiley- 22 (a) K. A. Connors, Binding Constants: The Measurement of
Blackwell, 3rd edn, 2009, pp. 585–603; (c) N. L. Harrison
and M. A. Simmonds, Br. J. Pharmacol., 1983, 80, 387; (d)
Molecular Complex Stability, Wiley-VCH, Weinheim, 1987;
(b) C. W. Davies, Ion association, Butterworths,
Washington, 1962, ch. 4.
¨
W. Loscher and M. A. Rogawski, Epilepsia, 2012, 53, 12; (e)
M. Bialer, Epilepsia, 2012, 53, 3.
26756 | RSC Adv., 2014, 4, 26748–26756
This journal is © The Royal Society of Chemistry 2014